S. Jackson

发表

Factor product utilization and health outcomes in patients with haemophilia A and B on extended half‐life concentrates: A Canadian observational study of real‐world outcomes

A. Iorio, V. Blanchette, M. Carcao, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

A Study of Thrombophilia Testing and Counseling Practices of Family Physicians Using the Script Concordance Method in Calgary, Canada

M. Poon, S. Jackson, N. Schneider-MacRae, 2012, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Helicobacter pylori eradication: Novel therapy for immune thrombocytopenic purpura? A review of the literature

G. Pineo, M. Poon, P. Beck, 2005, American journal of hematology.

Low oxygen saturation by pulse oximetry may be associated with a low oxygen affinity hemoglobin variant, hemoglobin Titusville.

M. Poon, S. Spier, R. Deyell, 2006, Journal of pediatric hematology/oncology.

Prevalence and predictors of loss to follow‐up in young adults with mild haemophilia

L. De Marchi, S. Jackson, E. Crilly, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Adult males with haemophilia have a different macrovascular and microvascular endothelial function profile compared with healthy controls

M. Poon, T. Anderson, S. Jackson, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Joining the patient on the path to customized prophylaxis: one hemophilia team explores the tools of engagement

Nicole M. Summers, H. Sun, Ming Yang, 2015, Journal of multidisciplinary healthcare.

Outcomes indicators and processes in transitional care in adolescents with haemophilia: A Delphi survey of Canadian haemophilia care providers

V. Breakey, L. Straatman, H. Sun, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Desmopressin for bleeding in non‐severe hemophilia A: Suboptimal use in a real‐world setting

J. Eikenboom, M. Kruip, G. Castaman, 2022, Research and practice in thrombosis and haemostasis.

Long term platelet responses to Helicobacter pylori eradication in Canadian patients with immune thrombocytopenic purpura

P. M. O'Connor, A. Buret, G. Pineo, 2008, International journal of hematology.

Diabetes, hepatitis C and human immunodeficiency virus influence hypertension risk differently in cohorts of haemophilia patients, veterans and the general population

D. Quon, R. Kruse-Jarres, R. Barnes, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy.

B. Leber, T. A. Lister, J. Fitzgibbon, 2008, Blood.

Erectile dysfunction in patients with haemophilia

H. Sun, Ming Yang, S. Jackson, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Recognizing the need for personalization of haemophilia patient‐reported outcomes in the prophylaxis era

E. Neufeld, K. Rockwood, M. Recht, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Point of care ultrasonography in haemophilia care: recommendations for training and competency evaluation

A. Iorio, Anthony K. C. Chan, S. Jackson, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

platelet disorder with propensity to myeloid malignancy Five new pedigrees with inherited RUNX1 mutations causing familial

B. Leber, T. A. Lister, M. Poon, 2013 .

Suspected collagen disorders in the bleeding disorder clinic: A case–control study

J. Bom, M. Poon, R. Card, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Goal Attainment Scaling for haemophilia (GAS‐Hēm): testing the feasibility of a new patient‐centric outcome measure in people with haemophilia

K. Rockwood, M. Recht, K. Robinson, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Clinical practice of personalized prophylaxis in hemophilia: Illustrations of experiences and benefits from two continents

C. Hermans, C. Santoro, A. Ferretti, 2019, Clinical case reports.

Observational Study of Real-World Factor Utilization and Health Outcomes in Patients with Hemophilia in Canada

A. Iorio, V. Blanchette, R. Klaassen, 2018, Blood.

Switching to extended half‐life products in Canada – preliminary data

A. Iorio, M. Carcao, V. Bouskill, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Issues in the ageing individual with haemophilia and other inherited bleeding disorders: understanding and responding to the patients’ perspective

N. Smith, S. Jackson, C. Bartholomew, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Patient‐centred care in haemophilia: Patient perspectives on visualization and participation in decision‐making

J. G. van der Bom, S. Gouw, R. Sawatzky, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Point‐of‐care ultrasonography in haemophilia care: Training and competency for muscular haematomas

A. Iorio, Anthony K. C. Chan, S. Jackson, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Patient‐relevant health outcomes for hemophilia care: Development of an international standard outcomes set

A. Iorio, V. Blanchette, B. Konkle, 2021, Research and practice in thrombosis and haemostasis.

Trends of outcomes and healthcare utilization following orthopaedic procedures in adults with haemophilia: A 3‐decade retrospective review

S. Jackson, Farshad Hosseini, C. Lin, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Patient powered prophylaxis: A 12‐month study of individualized prophylaxis in adults with severe haemophilia A

P. Camp, H. Sun, Ming Yang, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Men, Masculinities, and Hemophilia

L. Currie, J. Oliffe, S. Jackson, 2016, American journal of men's health.

Clinical haemophilia Long-term safety and efficacy of recombinant factor VIII Fc fusion protein ( rFVIIIFc ) in subjects with haemophilia

D. Perry, B. Konkle, K. Pasi, 2016 .

Long-Term Safety and Efficacy of Recombinant Factor VIII FC (RFVIIIFC) in Adults and Adolescents With Severe Haemophilia A: An Interim Analysis of The ASPIRE Study

D. Perry, B. Konkle, J. Mahlangu, 2015 .

Long‐acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B‐LONG study

C. Hermans, D. Perry, M. Ozelo, 2015, British journal of haematology.

Long-lasting recombinant factor FIX Fc fusion (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG study

C. Hermans, H. Chambost, J. Mahlangu, 2013 .

Patterns of tertiary prophylaxis in Canadian adults with severe and moderately severe haemophilia B

A. Iorio, M. Sholzberg, M. Poon, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Pain management strategies in adults with haemophilia: a retrospective study

M. Yang, S. Jackson, X. Wang, 2015, Haemophilia.

Blood pressure in haemophilia and its relation to clotting factor usage

D. Quon, R. Barnes, H. Sun, 2019, The Journal of Haemophilia Practice.

Blood pressure in persons with haemophilia with a focus on haemophilia‐specific risk factors

D. Quon, R. Kruse-Jarres, A. Drygalski, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Haematuria is not a risk factor of hypertension or renal impairment in patients with haemophilia

A. Drygalski, S. Jackson, A. S. Sait, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Cardiovascular disease (CVD) in Canadians with haemophilia: Age‐Related CVD in Haemophilia Epidemiological Research (ARCHER study)

A. Iorio, B. Chin-Yee, M. Poon, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Prophylaxis in older Canadian adults with hemophilia A: lessons and more questions

A. Iorio, M. Sholzberg, M. Poon, 2015, BMC Hematology.

Vocational experiences and career support opportunities among Canadian men with moderate and severe haemophilia

N. Smith, S. Lane, S. Jackson, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

A Practical, One-Clinic Visit Protocol for Pharmacokinetic Profile Generation with the ADVATE myPKFiT Dosing Tool in Severe Hemophilia A Subjects

J. Blatny, M. Morfini, V. Blanchette, 2021, Thrombosis and Haemostasis.

An objective method for assessing adherence to prophylaxis in adults with severe haemophilia

S. Jackson, M. Bucevska, K. McIntosh, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Long‐term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia A

D. Perry, B. Konkle, K. Pasi, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Supply and demand for hemophilia treatments-Systems-based approaches to mitigate the risk.

J. Teitel, S. Jackson, J. Stoffman, 2018, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

The impact of extended half‐life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B

A. Iorio, V. Blanchette, M. Carcao, 2021, Research and practice in thrombosis and haemostasis.

The Montreal platelet syndrome kindred has type 2B von Willebrand disease with the VWF V1316M mutation.

M. Poon, S. Cloutier, Zhao-xia Duan, 2009, Blood.

Desmopressin in moderate hemophilia A patients: a treatment worth considering

J. Voorberg, E. Santagostino, M. Carcao, 2018, Haematologica.

Long-Term Safety and Efficacy of rFVIIIFc in Adults and Adolescents with Severe Hemophilia A: A Longitudinal Analysis of A-LONG and ASPIRE

D. Perry, B. Konkle, K. Pasi, 2015 .

Risk of diabetes in haemophilia patients compared to clinic and non‐clinic control cohorts

D. Quon, R. Kruse-Jarres, R. Barnes, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Cardiovascular disease prevalence and relevance in haemophilia: a scoping review

A. Iorio, L. Minuk, S. Jackson, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Helicobacter pylori Activates Calpain via Toll-Like Receptor 2 To Disrupt Adherens Junctions in Human Gastric Epithelial Cells

P. M. O'Connor, A. Buret, P. Beck, 2011, Infection and Immunity.

2B or not to be – The 45-year saga of the Montreal Platelet Syndrome

M. Poon, M. Rand, S. Jackson, 2010, Thrombosis and Haemostasis.

Inhibitor Risk Stratification and Individualized Treatment in Patients With Nonsevere Hemophilia A: A Single-Institution Practice Audit

P. Yenson, S. Jackson, H. Sun, 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Willebrand disease with the VWF V1316M mutation

Zhao-xia, M. Poon, S. Cloutier, 2013 .

Assessing baseline joint hypermobility as a risk factor for arthropathy development in moderate and severe haemophilia

M. Poon, S. Jackson, L. Skeith, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

Long‐acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B‐LONG study

C. Hermans, D. Perry, M. Ozelo, 2015, British journal of haematology.